[
    {
        "content": "* Amazon also expected to muscle in on prescription drugs (Adds details of online mail order in OTC  prescription drugs)",
        "date": "11152017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 2-Bayer hires new blood to stem 'Amazon effect' in consumer health "
    },
    {
        "content": "* Mckesson strengthens its portfolio of manufacturer solutions with the acquisition of RxCrossroads",
        "date": "11062017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson acquires RxCrossroads in a deal valued at $735 mln "
    },
    {
        "content": "Drug distributor McKesson Corp  said on Monday it would buy drugstore operator CVS Health Corp's  unit that provides various tailored services to pharma firms in a $735 million deal to expand the range of services it offers.",
        "date": "11062017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "Drug distributor McKesson to buy CVS Health's services unit "
    },
    {
        "content": "Nov 6 Drug distributor McKesson Corp said on Monday it would buy drugstore operator CVS Health Corp's unit that provides various tailored services to pharma firms in a $735 million deal to expand the range of services it offers.",
        "date": "11062017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 2-Drug distributor McKesson to buy CVS Health's services unit "
    },
    {
        "content": "Nov 6 Drug distributor McKesson Corp said on Monday it would buy rival CVS Health Corp's unit in a deal valued at $735 million in cash.",
        "date": "11062017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "Drug distributor McKesson to buy CVS Health's unit for $735 mln "
    },
    {
        "content": "* MCKESSON SIGNS AGREEMENT WITH NRG TO INSTALL SOLAR ARRAYS AT MCKESSON FACILITY",
        "date": "10302017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-MCKESSON SIGNS AGREEMENT WITH NRG TO INSTALL SOLAR ARRAYS AT MCKESSON FACILITY "
    },
    {
        "content": "McKesson Corp   the biggest U.S. drug distributor  posted a better-than-expected quarterly profit after a tie-up with Wal-Mart Stores Inc  helped it buy generic drugs at lower prices  sending its shares up nearly 6 percent on Thursday.",
        "date": "10262017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "Wal-Mart tie-up helps McKesson top profit estimates "
    },
    {
        "content": "* Shares up 6 pct; AmerisourceBergen  Cardinal Health gain (Adds comments from conference call  updates shares)",
        "date": "10262017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 3-Wal-Mart tie-up helps McKesson top profit estimates "
    },
    {
        "content": "Oct 26 Drug wholesaler McKesson Corp reported a better-than-expected quarterly profit  helped by strength in its distribution business.",
        "date": "10262017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 1-Drug distributor McKesson's quarterly profit beats estimates "
    },
    {
        "content": "* Q2 GAAP earnings per share $0.01 from continuing operations",
        "date": "10262017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-McKesson reports Q2 adjusted earnings per share $3.28 "
    },
    {
        "content": "Oct 26 Drug wholesaler McKesson Corp's quarterly profit plunged  hurt by restructuring and impairment charges.",
        "date": "10262017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "Drug distributor McKesson's qtrly profit plunges on charges "
    },
    {
        "content": "* Truveris has secured $25 million in a new round of funding led by McKesson Ventures Source text for Eikon:",
        "date": "09062017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-Truveris secures $25 mln in new funding round led by McKesson Ventures "
    },
    {
        "content": "McKesson Corp   the biggest U.S. drug distributor  posted a much lower-than-expected quarterly profit  hurt by the lingering effects of a slowdown in the pace of price increases for branded drugs  sending its shares down as much as 6 percent.",
        "date": "07272017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "McKesson profit dragged by tepid growth in branded drug prices "
    },
    {
        "content": "* James Beer  EVP  CFO of Mckesson Corporation  joins Alaska Air Group board of directors",
        "date": "08032017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-James Beer  EVP  CFO of Mckesson Corporation  joins Alaska Air board of directors "
    },
    {
        "content": "* Raises fiscal 2018 earnings forecast to $11.80-$12.50/share",
        "date": "07272017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 3-McKesson profit dragged by tepid growth in branded drug prices "
    },
    {
        "content": "* Allscripts to acquire Mckesson\u2019s enterprise information solutions business",
        "date": "08032017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-Allscripts to acquire Mckesson\u2019s Enterprise Information Solutions business "
    },
    {
        "content": "* Q1 GAAP earnings per share $1.44 from continuing operations",
        "date": "07272017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson reports fiscal 2018 first-quarter results "
    },
    {
        "content": "Drug distributor AmerisourceBergen Corp  cut its fiscal 2017 revenue growth forecast on Thursday and warned investors of the continuing fall in generic drug prices  adding that the pace of branded drug price increases could slow further.",
        "date": "08032017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "Drug pricing pressure weighs on AmerisourceBergen forecast "
    },
    {
        "content": "July 27 Drug wholesaler McKesson Corp reported a 43 percent fall in quarterly profit due to slower increase in drug prices and intensifying competition.",
        "date": "07272017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson quarterly profit falls 43 pct "
    },
    {
        "content": "* Shares fall as much as 11 pct; rivals also slump (Adds conf call details  analysts' comments  updates shares)",
        "date": "08032017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 3-Drug pricing pressure weighs on AmerisourceBergen forecast "
    },
    {
        "content": "McKesson Corp's shareholders voted against the company's executive pay policy  following a campaign that criticized the drug wholesaler for its role in the U.S. opioid drug epidemic.",
        "date": "07262017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "McKesson shareholders vote against executive pay structure "
    },
    {
        "content": "July 25 U.S. state treasurers from Illinois  Pennsylvania and West Virginia on Tuesday urged drug distributor McKesson Corp to appoint an independent chair and link executive pay with progress in combating opioid epidemic.",
        "date": "07252017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "UPDATE 1-Three US state treasurers seek change in McKesson exec pay policy "
    },
    {
        "content": "July 26 McKesson Corp's shareholders voted against the company's executive pay policy  following a campaign that criticized the drug wholesaler for its role in the U.S. opioid drug epidemic.",
        "date": "07262017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 1-McKesson shareholders vote against exec pay structure "
    },
    {
        "content": "July 25 U.S. state treasurers from Illinois  Pennsylvania and West Virginia on Tuesday urged drug distributor McKesson Corp to appoint an independent chair and link executive pay with progress in combating opioid epidemic.",
        "date": "07252017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "Three US state treasurers seek change in McKesson exec pay policy "
    },
    {
        "content": "* Mckesson announces preliminary voting results from 2017 annual meeting of stockholders",
        "date": "07262017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-McKesson says shareholders vote against executive pay structure "
    },
    {
        "content": "July 25 State Treasurers of Illinois  Pennsylvania and West Virginia:",
        "date": "07252017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-Three U.S. state treasurers ask McKesson to help address opioid epidemic "
    },
    {
        "content": "July 26 McKesson Corp shareholders voted against the company's executive pay policy  following a shareholder campaign that criticized the drug wholesaler for its role in the U.S. opioid drug epidemic.",
        "date": "07262017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson shareholders vote against exec pay structure "
    },
    {
        "content": "NEW YORK  July 10 The International Brotherhood of Teamsters urged McKesson Corp's shareholders to vote against the company's executive pay practices and called for it to appoint an independent chairman as the union criticized the drug distributor for its role in the U.S. opioid drug epidemic.",
        "date": "07102017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "Teamsters urge McKesson shareholders to vote against CEO pay "
    },
    {
        "content": "* FY2018 earnings per share view $12.14  revenue view $205.28 billion -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:",
        "date": "06282017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-McKesson reaffirms fiscal 2018 guidance "
    },
    {
        "content": "* CEO John Hammergren's FY 2017 total compensation was $20.1 million versus $23.6 million in fy 2016 - SEC filing",
        "date": "06162017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson CEO John Hammergren's FY2017 total compensation was $20.1 mln "
    },
    {
        "content": "* Sets regular quarterly dividend of $0.28/share Source text for Eikon: Further company coverage:",
        "date": "05242017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-McKesson sets regular quarterly dividend of $0.28/share "
    },
    {
        "content": "McKesson Corp  reported a higher-than-expected quarterly profit and forecast an upbeat full-year earnings  easing concerns about the drug wholesaler's struggles with moderating branded drug price increases and falling prices for generics.",
        "date": "05182017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "Drug distributor McKesson's upbeat forecast sends shares soaring "
    },
    {
        "content": "May 18 McKesson Corp reported a higher-than-expected quarterly profit and forecast an upbeat full-year earnings  easing concerns about the drug wholesaler's struggles with moderating branded drug price increases and falling prices for generics.",
        "date": "05182017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 2-Drug distributor McKesson's upbeat forecast sends shares soaring "
    },
    {
        "content": "May 18 Drug wholesaler McKesson Corp reported a 4.4 percent rise in quarterly revenue  helped by strength in its pharmaceutical distribution and services business.",
        "date": "05182017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "Drug distributor McKesson's quarterly revenue rises 4.4 pct "
    },
    {
        "content": "* As a result of net gain from transaction  co to add about $10.70-$12.35 in Q4 GAAP earnings per share from continuing operations",
        "date": "03022017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson anticipates recording pre-tax gain of about $2.9 to $3.5 bln in Q4 "
    },
    {
        "content": "(The following statement was released by the rating agency) NEW YORK  February 13 (Fitch) Fitch Ratings has assigned 'BBB+' ratings to the  EUR and GBP denominated senior unsecured notes issued by McKesson Corp. (NYSE:  MCK). A full list of ratings follows at the end of the release.  KEY RATING DRIVERS Stable Operations  Low Margins The credit profiles of MCK and its peers benefit from stable operating profiles  and consistent cash generation. Steady pharmaceutical demand  an oligopolistic  drug",
        "date": "02132017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "Fitch Rates McKesson's EUR and GBP Notes 'BBB+'; Outlook Stable "
    },
    {
        "content": "Jan 31 Buyout firm Thoma Bravo LLC is exploring a sale of Global Health Exchange (GHX)  a software company that helps track medical and surgical supplies that could be worth as much as $1.3 billion  including debt  according to people familiar with the matter.",
        "date": "01312017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "Thoma Bravo explores sale of Global Health Exchange-sources "
    },
    {
        "content": "* McKesson announces purchase of CoverMyMeds  a Francisco Partners portfolio company",
        "date": "01262017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson announces purchase of CoverMyMeds "
    },
    {
        "content": "Drug distributor McKesson Corp's  quarterly revenue missed estimates due to slowing pace of branded drug price increases amid rising concerns over soaring prices of medicines.",
        "date": "01252017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "McKesson's revenue misses as pace of drug price hikes slow "
    },
    {
        "content": "Jan 25 Drug distributor McKesson Corp's  quarterly revenue missed estimates due to slowing pace of branded drug price increases amid rising concerns over soaring prices of medicines.",
        "date": "01252017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 2-McKesson's revenue misses as pace of drug price hikes slow "
    },
    {
        "content": "McKesson Corp  one of the largest U.S. distributors of pharmaceutical drugs  will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers.",
        "date": "01182017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "McKesson in record $150 mln U.S. settlement over suspicious drug orders "
    },
    {
        "content": "* Q3 gaap earnings per share $2.86 from continuing operations",
        "date": "01252017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-McKesson to acquire CoverMyMeds for about $1.1 bln "
    },
    {
        "content": "Jan 25 Drug wholesaler McKesson Corp  said it would buy privately held CoverMyMeds for about $1.1 billion to strengthen its technology offerings to pharmaceutical manufacturers  clinicians and health insurers.",
        "date": "01252017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson to buy CoverMyMeds for $1.1 bln "
    },
    {
        "content": "McKesson Corp  one of the largest U.S. distributors of pharmaceutical drugs  will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers.",
        "date": "01172017",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "McKesson in record $150 million U.S. settlement over suspicious drug orders "
    },
    {
        "content": "Jan 17 McKesson Corp  one of the largest U.S. distributors of pharmaceutical drugs  will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers.",
        "date": "01172017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 1-McKesson in record $150 mln U.S. settlement over suspicious drug orders "
    },
    {
        "content": "* McKesson finalizes settlement with U.S. Department of Justice and U.S. Drug enforcement administration to resolve past claims",
        "date": "01172017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "REFILE-BRIEF-McKesson finalizes settlement with DOJ and DEA to resolve past claims "
    },
    {
        "content": "WASHINGTON  Jan 17 McKesson Corp  one of the largest U.S. distributors of pharmaceutical drugs  has agreed to pay a record $150 million civil penalty for allegedly failing to report suspicious drug orders  the U.S. Justice Department said on Tuesday.",
        "date": "01172017",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson to pay record $150 mln settlement over suspicious drug orders -U.S. "
    },
    {
        "content": "* Mckesson placed its first order for stock which will be delivered by end of december",
        "date": "11132016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-Medical Developments International says Trump's election will not negatively impact co "
    },
    {
        "content": "NEW YORK  Oct 28 Shares of the three major U.S. prescription drug wholesalers tumbled on Friday as investors feared a pricing war after McKesson Corp's quarterly report that rippled through the pharmaceutical supply chain.",
        "date": "10282016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "U.S. drug wholesaler shares tumble on pricing-war fears "
    },
    {
        "content": "* Sets regular quarterly dividend of $0.28per share  Source text for Eikon:  Further company coverage:",
        "date": "10272016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-McKesson sets regular quarterly dividend of $0.28per share "
    },
    {
        "content": "* Varian and McKesson Specialty Health announce strategic agreement for advanced radiotherapy equipment and software  Source text for Eikon:  Further company coverage:",
        "date": "10262016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-Varian and McKesson Specialty Health announces strategic agreement "
    },
    {
        "content": "FRANKFURT  Sept 15 Germany's antitrust regulator raided eight drug wholesale companies  including a subsidiary of U.S. healthcare services provider McKesson Corp  on suspicion of illegal collusion.",
        "date": "09152016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "German antitrust watchdog raids drugs distributors "
    },
    {
        "content": "* Received a request for additional information and documentary material from u.s. Doj pursuant to hart-scott-rodino antitrust improvements act",
        "date": "09062016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson received request from U.S. DOJ pursuant to Hart-Scott-Rodino Antitrust improvements act "
    },
    {
        "content": "* Fy2017 earnings per share view $13.64 -- Thomson Reuters I/B/E/S",
        "date": "07272016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson Q1 GAAP EPS $2.88 from continuing operations "
    },
    {
        "content": "* UK's CMA says decided not to refer merger by Mckesson Corp unit AAH Pharmaceuticals of MASTA and Sangers to a Phase 2 investigation.  Source text for Eikon: (http://bit.ly/29eSv3J)    (Bengaluru Newsroom)",
        "date": "06292016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-UK's CMA says not refer Mckesson unit  AAH Pharma-UDG deal for phase 2 probe "
    },
    {
        "content": "Healthcare services provider McKesson Corp  said it would combine most of its information technology business with Change Healthcare Holdings Inc to form a new company with combined pro forma annual revenue of $3.4 billion.",
        "date": "06282016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "McKesson's IT unit to merge with Change Healthcare "
    },
    {
        "content": "* Companies will take steps to launch IPO after deal closes   (Adds Breakingviews link)",
        "date": "06282016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 3-McKesson's IT unit to merge with Change Healthcare "
    },
    {
        "content": "* McKesson to explore strategic alternatives for enterprise information solutions  Source text for Eikon:  Further company coverage:",
        "date": "06282016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-McKesson exploring strategic alternatives for enterprise information solutions "
    },
    {
        "content": "June 28 Healthcare services provider McKesson Corp said it would combine most of its technology solutions business with Change Healthcare Holdings Inc to form a new company with pro forma combined annual revenue of $3.4 billion.",
        "date": "06282016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson's tech solutions business to merge with Change Healthcare "
    },
    {
        "content": "* McKesson and Change Healthcare to form new healthcare information technology company",
        "date": "06282016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson and Change Healthcare to form new healthcare IT co "
    },
    {
        "content": "* Decided not to recommend McKesson Corp deal with Bupa Home Healthcare to a phase 2 investigation  Source text: http://bit.ly/292ycrB Further company coverage:    (Bengaluru Newsroom)",
        "date": "06282016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-UK's CMA says not to recommend McKesson-Bupa Home deal to in-depth investigation "
    },
    {
        "content": "McKesson Corp   one of the largest U.S. drug distributors  has held talks about merging its information technology unit with healthcare technology company Change Healthcare Inc  three people familiar with the matter said.",
        "date": "06212016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "Exclusive: McKesson considers IT unit merger with Change Healthcare - sources "
    },
    {
        "content": "* CEO John Hammergren's FY 2016 total compensation was $23.6 million versus $24.8 million in FY 2015 - SEC filing",
        "date": "06172016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson CEO's 2016 compensation was $23.6 mln "
    },
    {
        "content": "NEW YORK  June 12 Shares of McKesson Corp  could rise more than 15 percent as the pharmaceutical distributor trims costs and gains new clients  according to a report in the financial publication Barron's.",
        "date": "06122016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "McKesson shares could rise 15 percent with cost savings -Barron's "
    },
    {
        "content": "U.S. drug distributor McKesson Corp is weighing a separation of its information technology unit McKesson Technology Solutions as the company grapples with pricing pressure in its core drug-distribution business  the Wall Street Journal said citing people familiar with the matter.",
        "date": "06032016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "McKesson considers separation of information technology unit: WSJ "
    },
    {
        "content": "June 3 U.S. drug distributor McKesson Corp  is weighing a separation of its information technology unit McKesson Technology Solutions as the company grapples with pricing pressure in its core drug-distribution business  the Wall Street Journal said citing people familiar with the matter.",
        "date": "06032016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson considers separation of information technology unit - WSJ "
    },
    {
        "content": "* Mckesson Corp considering separation of info tech unit  worth possibly more than $5 bln; could be spun off or merged with a rival - CNBC citing Dow Jones   Further company coverage:",
        "date": "06032016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson considering separation of info tech unit  worth possibly more than $5 bln - CNBC citing DJ "
    },
    {
        "content": "May 12 UK'S Competition and Markets Authority(CMA):",
        "date": "05122016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-UK's CMA says investigating UK aspects of McKesson-UDG deal "
    },
    {
        "content": "May 16 Retailing giant Wal-Mart Stores Inc  and U.S. drug distributor McKesson said on Monday they would expand an alliance for jointly procuring generic medicines in an attempt to lower costs.",
        "date": "05162016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "Wal-Mart expands generics procurement with McKesson "
    },
    {
        "content": "May 16 Retailer Wal-Mart Stores Inc said on Monday that it was expanding joint procurement of generic drugs with U.S. drug distributor McKesson to lower costs as it battles drug inflation and other pressures on its pharmacy business margins.",
        "date": "05162016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 1-Wal-Mart expands generics procurement with McKesson "
    },
    {
        "content": "* Organizations will collaborate on sourcing generic pharmaceuticals for their respective u.s. Operations  adding scale and value for both companies",
        "date": "05162016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-McKesson and Walmart announce sourcing agreement for generic pharmaceuticals "
    },
    {
        "content": "* Sees cost alignment plan to generate approximately $170 mln to $190 mln of net pre-tax savings during fiscal year ending March 31  2017",
        "date": "03182016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson announces restructuring plan to lower operating costs "
    },
    {
        "content": "U.S. drug distributor McKesson Corp  said on Wednesday it cut 1 600 jobs  or about 4 percent of its U.S. workforce  to slash costs after the company lost some key customers.",
        "date": "03172016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "McKesson cuts 1 600 jobs to trim costs "
    },
    {
        "content": "March 16 U.S. drug distributor McKesson Corp  said on Wednesday it cut 1 600 jobs  or about 4 percent of its U.S. workforce  to slash costs after the company lost some key customers.",
        "date": "03172016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 1-McKesson cuts 1 600 jobs to trim costs "
    },
    {
        "content": "* Mckesson Corp is firing 1 600 people  or about 4 percent of its U.S. Workforce  to cut costs- Bloomberg  citing e-mailed statement   Source (http://bloom.bg/1TPoNVa)   (Bengaluru Newsroom)",
        "date": "03172016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-Mckesson Corp is firing 1 600 people from its U.S. workforce- Bloomberg "
    },
    {
        "content": "BRUSSELS  March 4 The following are mergers under review by the European Commission and a brief guide to the EU merger process:",
        "date": "03042016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "EU mergers and takeovers (March 4) "
    },
    {
        "content": "BRUSSELS  March 2 The following are mergers under review by the European Commission and a brief guide to the EU merger process:",
        "date": "03022016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "EU mergers and takeovers (March 2) "
    },
    {
        "content": "U.S. drug distributor McKesson Corp  said it would buy drugstore chain Rexall Health from Katz Group for C$3 billion ($2.23 billion) to strengthen its position in Canada's pharmaceutical supply chain.",
        "date": "03022016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson to expand in Canada with Rexall Health buy "
    },
    {
        "content": "* Transaction to add to McKesson's fiscal 2017 profit   (Adds analyst comment  shares)",
        "date": "03022016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 3-McKesson to expand in Canada with Rexall Health buy "
    },
    {
        "content": "Drug distributor McKesson Corp  said it was buying two privately held cancer care service providers  Vantage Oncology LLC and Biologics Inc  for a total of $1.2 billion  to add muscle to its specialty health business.",
        "date": "02252016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "Drug distributor McKesson to buy two cancer care firms for $1.2 billion "
    },
    {
        "content": "March 2 Drug distributor McKesson Corp  said it would buy Rexall Health from Katz Group for C$3 billion ($2.23 billion) to strengthen its position in Canada's pharmaceutical supply chain.",
        "date": "03022016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson to buy Rexall Health for C$3 bln "
    },
    {
        "content": "Feb 25 Drug distributor McKesson Corp  said it was buying two privately held cancer care service providers  Vantage Oncology LLC and Biologics Inc  for a total of $1.2 billion  to add muscle to its specialty health business.",
        "date": "02252016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 1-Drug distributor McKesson to buy two cancer care firms for $1.2 bln "
    },
    {
        "content": "Feb 25 Drug distributor McKesson Corp  said it was buying two privately held cancer care companies  Vantage Oncology LLC and Biologics Inc  for a total of $1.2 billion to boost its specialty pharma distribution business.",
        "date": "02252016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson to buy two cancer care companies for $1.2 bln "
    },
    {
        "content": "BRUSSELS  Feb 17 The following are mergers under review by the European Commission and a brief guide to the EU merger process:",
        "date": "02172016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "EU mergers and takeovers (Feb 17) "
    },
    {
        "content": "BRUSSELS  Feb 16 The following are mergers under review by the European Commission and a brief guide to the EU merger process:",
        "date": "02162016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "EU mergers and takeovers (Feb 16) "
    },
    {
        "content": "BRUSSELS  Feb 10 The following are mergers under review by the European Commission and a brief guide to the EU merger process:",
        "date": "02102016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "EU mergers and takeovers (Feb 10) "
    },
    {
        "content": "BRUSSELS  Jan 15 The following are mergers under review by the European Commission and a brief guide to the EU merger process:",
        "date": "01152016",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "EU mergers and takeovers (Jan 15) "
    },
    {
        "content": "Jan 11 Drug distributor McKesson Corp  said its fiscal 2017 earnings are likely to be hit by weak generic drug pricing and narrowed its profit forecast for 2016.",
        "date": "01112016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson says 2017 profit to be hurt by weak generic drug pricing "
    },
    {
        "content": "* Indexes down: Dow 0.16 pct  S&P 0.32 pct  Nasdaq 0.52 pct   (Adds details  changes comment  updates prices)",
        "date": "01112016",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "US STOCKS-Wall St loses gains as health stocks  oil prices slide "
    },
    {
        "content": "Oct 29 With a lucrative supply deal hanging in the balance  drug distributor McKesson Corp moved to reassure investors on Thursday by announcing its retention of a contract with Omnicare  a supplier of prescription medicines to nursing homes.",
        "date": "10292015",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson plays up alternatives as Rite Aid deal hangs in balance "
    },
    {
        "content": "UDG Healthcare Plc  said it would sell its Irish drug distribution businesses to U.S. drug wholesaler McKesson Corp  for 407.5 million euros ($466 million) to cut debt and raise funds for acquisitions.",
        "date": "09182015",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "UDG Healthcare to sell two units to McKesson for $466 million "
    },
    {
        "content": "Sept 18 UDG Healthcare Plc said it would sell its Irish drug distribution businesses to U.S. drug wholesaler McKesson Corp for 407.5 million euros ($466 million) to cut debt and raise funds for acquisitions.",
        "date": "09182015",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 1-UDG Healthcare to sell two units to McKesson for $466 mln "
    },
    {
        "content": "Sept 18 UDG Healthcare Plc said it would sell its drug distribution units in Ireland and Northern Ireland and a unit in its commercial services business to U.S. drug wholesaler McKesson Corp for 407.5 million euros ($466 million).",
        "date": "09182015",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UDG Healthcare to sell two units to McKesson for $466 mln "
    },
    {
        "content": "* Proposed sale of United Drug Supply chain businesses and Masta to McKesson Corporation",
        "date": "09182015",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "BRIEF-UDG Healthcare to sell certain assets to McKesson for 407.5 mln euros "
    },
    {
        "content": "NEW YORK  July 27 Allergan plc CEO Brent Saunders is ready to put the $36 billion his company will net from the sale of its generics business to Teva Pharmaceutical Industries Ltd to work  possibly with another large  \"transformational\" merger.",
        "date": "07272015",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "UPDATE 1-Allergan CEO  fresh off one deal  sets sights on others "
    },
    {
        "content": "April 30 U.S. drug wholesaler McKesson Corp  said it settled with several federal agencies  including the Department of Justice  claims alleging suspicious order reporting practices for controlled substances.",
        "date": "04302015",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "McKesson settles investigation on controlled substances "
    },
    {
        "content": "Pharmacy service provider Omnicare Inc  is getting buyout interest from potential buyers  including Express Scripts Holding Co  and CVS Health Corp   Bloomberg reported  citing people with knowledge of the matter.",
        "date": "04302015",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "Omnicare draws buyout interest from CVS  Express Scripts: Bloomberg "
    },
    {
        "content": "April 30 Pharmacy service provider Omnicare Inc  is getting buyout interest from potential buyers  including Express Scripts Holding Co and CVS Health Corp  Bloomberg reported  citing people with knowledge of the matter.",
        "date": "04302015",
        "name": "McKesson Corporation",
        "news_type": "normal",
        "symbol": "MCK",
        "title": "Omnicare draws buyout interest from CVS  Express Scripts - Bloomberg "
    },
    {
        "content": "April 8 Rite Aid Corp reported a better-than-expected quarterly profit on Wednesday  and expected a renewed distribution agreement with McKesson Corp  along with the remodeling of its wellness stores to benefit fiscal 2016 earnings.",
        "date": "04082015",
        "name": "McKesson Corporation",
        "news_type": "topStory",
        "symbol": "MCK",
        "title": "UPDATE 2-Higher prescription sales help Rite Aid beat profit estimates "
    }
]